BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7533554)

  • 1. L-arginine induces dopamine release from the striatum in vivo.
    Strasser A; McCarron RM; Ishii H; Stanimirovic D; Spatz M
    Neuroreport; 1994 Nov; 5(17):2298-300. PubMed ID: 7533554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L- and D-enantiomers of N omega-nitro-arginine on NMDA-evoked striatal dopamine overflow.
    Ishida Y; Yamamoto R; Mitsuyama Y
    Brain Res Bull; 1994; 34(5):483-6. PubMed ID: 8082040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of striatal dopamine release in cerebral ischemia by L-arginine.
    Spatz M; Yasuma Y; Strasser A; Kawai N; Stanimirovic D; McCarron R
    Neurochem Res; 1995 Apr; 20(4):491-6. PubMed ID: 7651586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
    Richard MG; Bennett JP
    J Neurochem; 1995 May; 64(5):2080-6. PubMed ID: 7722491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors.
    Ohta K; Shimazu K; Komatsumoto S; Araki N; Shibata M; Fukuuchi Y
    Neuroreport; 1994 Mar; 5(7):766-8. PubMed ID: 7517194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain.
    Chaparro-Huerta V; Beas-Zárate C; Guerrero MU; Feria-Velasco A
    Neurochem Int; 1997 Oct; 31(4):607-16. PubMed ID: 9308011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study.
    West AR; Galloway MP
    Neurosci Lett; 1997 Jul; 230(1):21-4. PubMed ID: 9259454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide regulates NMDA-induced dopamine release in rat striatum.
    Shibata M; Araki N; Ohta K; Hamada J; Shimazu K; Fukuuchi Y
    Neuroreport; 1996 Jan; 7(2):605-8. PubMed ID: 8730840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-arginine produces NO-independent increases in dopamine efflux in rat striatum.
    Silva MT; Rose S; Hindmarsh JG; Jenner P; Marsden CD
    Neuroreport; 1998 Jan; 9(1):149-52. PubMed ID: 9592066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible role of nitric oxide in the regulation of dopamine transporter function in the striatum.
    Kiss JP; Hennings EC; Zsilla G; Vizi ES
    Neurochem Int; 1999 Apr; 34(4):345-50. PubMed ID: 10372921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in modulating neurotransmitter release from rat striatum.
    Sandor NT; Brassai A; Puskas A; Lendvai B
    Brain Res Bull; 1995; 36(5):483-6. PubMed ID: 7712211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neuronal nitric oxide synthase increases dopamine efflux from rat striatum.
    Silva MT; Rose S; Hindmarsh JG; Jenner P
    J Neural Transm (Vienna); 2003 Apr; 110(4):353-62. PubMed ID: 12658363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine-releasing action of 6R-L-erythro-tetrahydrobiopterin: analysis of its action site using sepiapterin.
    Koshimura K; Miwa S; Watanabe Y
    J Neurochem; 1994 Aug; 63(2):649-54. PubMed ID: 7518501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.
    Wegener G; Volke V; Rosenberg R
    Br J Pharmacol; 2000 Jun; 130(3):575-80. PubMed ID: 10821785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
    Volz TJ; Schenk JO
    Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different response to exogenous L-arginine in nitric oxide production between hippocampus and striatum of conscious rats: a microdialysis study.
    Hara S; Mukai T; Kurosaki K; Mizukami H; Kuriiwa F; Endo T
    Neurosci Lett; 2004 Aug; 366(3):302-7. PubMed ID: 15288439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nitric oxide synthase II inhibitor NG-nitro-L-arginine stimulates pancreatic islet insulin release in vitro, but not in the perfused pancreas.
    Jansson L; Sandler S
    Endocrinology; 1991 Jun; 128(6):3081-5. PubMed ID: 1709860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices.
    Zhu XZ; Luo LG
    J Neurochem; 1992 Sep; 59(3):932-5. PubMed ID: 1494918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole.
    Silva MT; Rose S; Hindmarsh JG; Aislaitner G; Gorrod JW; Moore PK; Jenner P; Marsden CD
    Br J Pharmacol; 1995 Jan; 114(2):257-8. PubMed ID: 7533610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.